Standard
Serum soluble CD163 predicts risk of type 2 diabetes in the general population. / Møller, Holger Jon; Frikke-Schmidt, Ruth; Moestrup, Søren; Nordestgaard, Børge G; Tybjærg-Hansen, Anne.
In:
Clinical Chemistry, Vol. 57, No. 2, 01.02.2011, p. 291-7.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Møller, HJ
, Frikke-Schmidt, R, Moestrup, S
, Nordestgaard, BG & Tybjærg-Hansen, A 2011, '
Serum soluble CD163 predicts risk of type 2 diabetes in the general population',
Clinical Chemistry, vol. 57, no. 2, pp. 291-7.
https://doi.org/10.1373/clinchem.2010.154724APA
Møller, H. J.
, Frikke-Schmidt, R., Moestrup, S.
, Nordestgaard, B. G., & Tybjærg-Hansen, A. (2011).
Serum soluble CD163 predicts risk of type 2 diabetes in the general population.
Clinical Chemistry,
57(2), 291-7.
https://doi.org/10.1373/clinchem.2010.154724Vancouver
Møller HJ
, Frikke-Schmidt R, Moestrup S
, Nordestgaard BG, Tybjærg-Hansen A.
Serum soluble CD163 predicts risk of type 2 diabetes in the general population.
Clinical Chemistry. 2011 Feb 1;57(2):291-7.
https://doi.org/10.1373/clinchem.2010.154724Author
Møller, Holger Jon ; Frikke-Schmidt, Ruth ; Moestrup, Søren ; Nordestgaard, Børge G ; Tybjærg-Hansen, Anne. / Serum soluble CD163 predicts risk of type 2 diabetes in the general population. In: Clinical Chemistry. 2011 ; Vol. 57, No. 2. pp. 291-7.
Bibtex
@article{05596694200742f9a605e697fde5f72c,
title = "Serum soluble CD163 predicts risk of type 2 diabetes in the general population",
abstract = "Activation of adipose tissue macrophages with concomitant low-grade inflammation is believed to play a central role in the development of type 2 diabetes. We tested whether a new macrophage-derived biomarker, soluble CD163 (sCD163), identifies at-risk individuals before overt disease has developed.",
author = "M{\o}ller, {Holger Jon} and Ruth Frikke-Schmidt and S{\o}ren Moestrup and Nordestgaard, {B{\o}rge G} and Anne Tybj{\ae}rg-Hansen",
year = "2011",
month = feb,
day = "1",
doi = "http://dx.doi.org/10.1373/clinchem.2010.154724",
language = "English",
volume = "57",
pages = "291--7",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry, Inc.",
number = "2",
}
RIS
TY - JOUR
T1 - Serum soluble CD163 predicts risk of type 2 diabetes in the general population
AU - Møller, Holger Jon
AU - Frikke-Schmidt, Ruth
AU - Moestrup, Søren
AU - Nordestgaard, Børge G
AU - Tybjærg-Hansen, Anne
PY - 2011/2/1
Y1 - 2011/2/1
N2 - Activation of adipose tissue macrophages with concomitant low-grade inflammation is believed to play a central role in the development of type 2 diabetes. We tested whether a new macrophage-derived biomarker, soluble CD163 (sCD163), identifies at-risk individuals before overt disease has developed.
AB - Activation of adipose tissue macrophages with concomitant low-grade inflammation is believed to play a central role in the development of type 2 diabetes. We tested whether a new macrophage-derived biomarker, soluble CD163 (sCD163), identifies at-risk individuals before overt disease has developed.
U2 - http://dx.doi.org/10.1373/clinchem.2010.154724
DO - http://dx.doi.org/10.1373/clinchem.2010.154724
M3 - Journal article
VL - 57
SP - 291
EP - 297
JO - Clinical Chemistry
JF - Clinical Chemistry
SN - 0009-9147
IS - 2
ER -
